OptimizeRx Corp is engaged in the healthcare market in the United States... Show more
a provider of unique consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products
Industry ServicestotheHealthIndustry
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IFRA | 55.53 | 0.50 | +0.91% |
| iShares U.S. Infrastructure ETF (IFRA) | |||
| NMB | 23.16 | 0.05 | +0.19% |
| Simplify National Muni Bond ETF (NMB) | |||
| MUNA | 98.44 | 0.10 | +0.10% |
| Northern Trust 2030 Tax-Exempt Distributing Ladder ETF (MUNA) | |||
| SPPP | 13.32 | -0.11 | -0.82% |
| Sprott Physical Platinum and Palladium Trust | |||
| HOOY | 26.43 | -0.66 | -2.44% |
| YieldMax HOOD Option Income Strategy ETF | |||
A.I.dvisor indicates that over the last year, OPRX has been loosely correlated with DOCS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if OPRX jumps, then DOCS could also see price increases.
| Ticker / NAME | Correlation To OPRX | 1D Price Change % | ||
|---|---|---|---|---|
| OPRX | 100% | +0.48% | ||
| DOCS - OPRX | 42% Loosely correlated | +0.56% | ||
| CXM - OPRX | 38% Loosely correlated | +5.45% | ||
| COIN - OPRX | 37% Loosely correlated | +1.54% | ||
| RIOT - OPRX | 36% Loosely correlated | -2.68% | ||
| CERT - OPRX | 35% Loosely correlated | +1.52% | ||
More | ||||
| Ticker / NAME | Correlation To OPRX | 1D Price Change % |
|---|---|---|
| OPRX | 100% | +0.48% |
| Services to the Health Industry industry (42 stocks) | 22% Poorly correlated | +2.69% |
| Health Services industry (241 stocks) | -3% Poorly correlated | +0.71% |
The Moving Average Convergence Divergence (MACD) for OPRX turned positive on September 25, 2026. Looking at past instances where OPRX's MACD turned positive, the stock continued to rise in 35 of 44 cases over the following month. The odds of a continued upward trend are 80%.
The Momentum Indicator moved above the 0 level on September 22, 2026. You may want to consider a long position or call options on OPRX as a result. In 62 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 70%.
Following a +5.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where OPRX advanced for three days, in 194 of 262 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OPRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
OPRX broke above its upper Bollinger Band on September 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. OPRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.122) is normal, around the industry mean (7.432). P/E Ratio (31.240) is within average values for comparable stocks, (46.656). Projected Growth (PEG Ratio) (1.608) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (1.463) is also within normal values, averaging (6.065).
The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OPRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.